Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Intensity modulated radiotherapy dosimetry with ion chambers, TLD, MOSFET and EDR2 film

Abstract

Purpose of this study was to report in a together our experience of using ion chambers, TLD, MOSFET and EDR2 film for dosimetric verification of IMRT plans delivered with dynamic multileaf collimator (DMLC). Two ion chambers (0.6 and 0.13 CC) were used. All measurements were performed with a 6MV photon beam on a Varian Clinac 6EX LINAC equipped with a Millennium MLC. All measurements were additionally carried out with (LiF:Mg,TI) TLD chips. Five MOSFET detectors were also irradiated. EDR2 films were used to measure coronal planar dose for 10 patients. Measurements were carried out simultaneously for cumulative fields at central axis and at off-axis at isocenter plane (±1, and ±2cm). The mean percentage variation between measured cumulative central axis dose with 0.6 cc ion chamber and calculated dose with TPS was −1.4% (SD 3.2). The mean percentage variation between measured cumulative absolute central axis dose with 0.13 cc ion chamber and calculated dose with TPS was −0.6% (SD 1.9). The mean percentage variation between measured central axis dose with TLD and calculated dose with TPS was −1.8% (SD 2.9). A variation of less than 5% was found between measured off-axis doses with TLD and calculated dose with TPS. For all the cases, MOSFET agreed within ±5%. A good agreement was found between measured and calculated isodoses. Both ion chambers (0.6 CC and 0.13 CC) were found in good agreement with calculated dose with TPS.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Galvin, J. M., Ezzell, G., Eisbrauch, A., Yu, C., Butler, B., Xiao, Y., Rosen, I., Rosenman, J., Sharpe, M., Xing, L., Xia, P., Lomax, T., Low, D. A. and Palta, J.Implementing IMRT in clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int. J. Radiat. Oncol., Biol., Phys., 58, 1616–34, 2004.

  2. 2.

    Ezzell, G. A., Galvin, J. M., Low, D. A., Palta, J. R., Rosen, I., Sharpe, M. B., Xia, P., Xiao, Y., Xing, L. and Yu, C. X.Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee, Medical Physics, 30, 2089–2115, 2003.

  3. 3.

    Gillis, S., Wagter, C. D., Bohsung, J., Perrin, B., Williams, P. and Mijnheer, B. J.An inter-centre quality assurance network for IMRT verification: Results of the ESTRO QUASIMODO project, Radiother. Oncol. 76, 340–353, 2005.

  4. 4.

    Van, E. A., Bohsung, J., and Sorvari, P.Acceptance tests and quality control (QC) procedures for theclinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departments, Radiother. Oncol. 70, 53–70, 2002.

  5. 5.

    Arnfield, M. R., Wu, Q., Tong, S., and Mohan, R.Dosimetric validation for multileaf collimator-based intensity-modulated radiotherapy: A review, Med. Dosim. 26, 179–188, 2001.

  6. 6.

    Leybovich, L. B., Sethi, A., and Dogan, N.Comparison of ionization chambers of various volumes for IMRT absolute dose verification, Med Phys, 30, 119–23, 2003.

  7. 7.

    Bouchard, H. and Seuntjens, J.Ionization chamber-based reference dosimetry of intensity modulated radiation beams, Med. Phys. 31, 2454–65, 2004.

  8. 8.

    Doblado, F., Capote, R., Rosello, J. V., Leal, A., Lagares, J. I., Arrans, R. and Hartmann, G. H.Micro ionization chamber dosimetry in IMRT verification: Clinical implications of dosimetric errors in the PTV, Radiother. Oncol. 75, 342–8, 2005.

  9. 9.

    Chuang, C. F., Verhey, L. J. and Xia, P.Investigation of the use of MOSFET for clinical IMRT dosimetric verification, Med. Phys. 29, 1109–15, 2002.

  10. 10.

    Shi, C., Papanikolaou, N., Yan, Y., Weng, X. and Jiang, H.Analysis of the sources of the source of uncertainty for EDR2 film-based IMRT quality assurance, J. Appl. Clin. Med. Phys. 7, 1–8, 2006.

  11. 11.

    Kulasekere, R., Moran, J. M., Fraass, B. A. and Roberson, P. L.Accuracy of rapid radiographic film calibration for intensity-modulated radiation therapy verification, J. Appl. Clin. Med. Phys. 7, 86–95, 2006.

  12. 12.

    Moran, J. M., Radawski, J. and Fraass, B. A.A dose-gradient analysis tool for IMRT QA, J. Appl. Clin. Med. Phys. 6, 62–72, 2005.

  13. 13.

    Halvorsen, P. H.Dosimetric evaluation of a new design MOSFET in vivo dosimeter, Med Phys. 32, 110–7, 2005.

  14. 14.

    Kinhikar R. A., Sharma P. K., Tambe C. M. and Deshpande D. D.Dosimetric evaluation of a new OneDose MOSFET for Ir-192 energy, Phys Med Biol. 51, 1261–8, 2006.

  15. 15.

    Kinhikar, R. A., Sharma, P. K., Tambe, C. M., Mahantshetty, U. M., Sarin, R., Deshpande, D. D. and Shrivastava, S. K.Clinical application of Onedose Mosfet for skin dose measurements during internal mammary chain irradiation with high dose rate brachytherapy in Carcinoma of Breast, Phys Med Biol. 51, N263-N268, 2006.

  16. 16.

    Low, D. A., Harms, W. B. and Mutic, S.A technique for the quantitative evaluation of dose distributions, Med. Phys. 25, 656–61, 1998.

  17. 17.

    Low, D. A. and Dempsey, J. F.Evaluation of the gamma dose distribution comparison method, Med. Phys. 30, 2455–64, 2003.

  18. 18.

    Depuydt, T., Esch, A. V. and Huyskens, D. P.A quantitative evaluation of IMRT dose distributions: Refinement and clinical assessment of the gamma evaluation, Radiother Oncol. 62, 309–19, 2002.

  19. 19.

    Papatheodorou, S., Rosenwald, J. C. and Zefkili, S.Dose calculation and verification of intensity modulation generated by multilieaf collimators, Med. Phys. 27, 960–71, 2000.

  20. 20.

    Chen, Z., Xing, L. and Nath, R.Independent monitor unit calculation for IMRT using MIMiC multileaf collimator, Med. Phys. 29, 2041–51, 2002.

  21. 21.

    Tsai, J. S., Wazer, D. E., and Ling, M. N.Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients, Int. J. Radiat. Oncol.Biol. Phys. 40, 1213–30, 1998.

  22. 22.

    Xia, P. and Change, C.Patients specific quality assurance in IMRT, In: Palta, J. R., Mackie, T. R., editors. Intensity-Modulated Radiation Therapy.The State of the Art.Medical Physics Monograph No. 29. Madison, WI: Medical Physics Publishing; 495–514, 2003.

  23. 23.

    Olch, A. J.Dosimetric accuracy of the ITP™ inverse treatment planning system, Med. Phys. 29, 2484–88, 2002.

  24. 24.

    Kapulsky, A., Mullokandov, E. and Gejerman, G.An automated phantom-film QA procedure for intensitymodulated radiation therapy, Med. Dosim. 27, 201–207, 2002.

  25. 25.

    Palta, J. R., Kim, S. and Liu, C.Tolerance limits and action levels for planning and delivery of IMRT. In: Palta, J. R., Mackie, T. R., editors.Intensity-Modulated Radiation Therapy. The State of the Art. Medical Physics Monograph No. 29. Madison, WI: Medical Physics Publishing; 593–612, 2003.

  26. 26.

    American Association of Physicists in Medicine. Radiation Therapy Committee Task Group 53:Quality assurance for clinical radiotherapy treatment planning. Med. Phys. 25, 1773–829, 1998.

Download references

Author information

Correspondence to R. A. Kinhikar.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kinhikar, R.A., Upreti, R., Sharma, S. et al. Intensity modulated radiotherapy dosimetry with ion chambers, TLD, MOSFET and EDR2 film. Australas. Phys. Eng. Sci. Med. 30, 25 (2007). https://doi.org/10.1007/BF03178406

Download citation

Key words

  • IMRT
  • Ion chambers
  • TLD
  • MOSFET
  • EDR2 film